Skip to main content

Table 1 VE (vaccine efficacy) methods, interpretation, and formulas

From: Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?

Method

Meaning

Formula

VERR

Vaccine-induced proportion reduction in probability of infection during follow-up

\({\mathrm{VE}}_{\mathrm{RR}}= 1-\mathrm{RR}= 1-\frac{{\mathrm{p}}_{\mathrm{v}}}{{\mathrm{p}}_{\mathrm{c}}}\)

VEHR

Vaccine-induced proportion reduction in hazard of first infection during follow-up

\({\mathrm{VE}}_{\mathrm{HR}}=\) 1 – HR

VEmolFOI

Vaccine-induced proportion reduction in molecular force of infection (molFOI)

VEmolFOI = \(1- \frac{\mathrm{molFOI\, of\, vaccinees}}{\mathrm{molFOI\, of\, controls}}\)

VEC

Vaccine-induced proportion reduction in mean number of clones per exposure that develop into a blood stage infection

\({\mathrm{VE}}_{C}= 1-\frac{{\overline{x} }_{v}}{{\overline{x} }_{c}}\mathrm{HR}\)

  1. RR,  risk ratio; \({p}_{v}\), proportion of vaccinees infected; \({p}_{c}\), proportion of controls infected;
  2. HR,  hazard ratio for time to first infection
  3. molFOI, incidence of new clones acquired over time = \(\frac{\begin{array}{c}Number \,of \,new \,clones \,acquired over \,follow-up, \,summed\\ over \,all \,members \,of \,the \,group\end{array}}{\mathrm{Total \,time \,in \,follow}-\mathrm{up \,in \,group}}\)
  4. \({\overline{x} }_{v}\), number of clones at first infection in vaccines; \({\overline{x} }_{c}\), number of clones at first infection in controls